Dr. Stephen S. Flitman, MD

Dr. Flitman practices at 21st Century Neurology in Phoenix, Arizona.

Dr. Flitman's NPI, 1023018223, was assigned on July 28, 2005. Dr. Flitman graduated from Albany Medical College in 1990. Dr. Flitman holds Arizona license 20626.

Dr. Flitman's primary practice is 21st Century Neurology, at 2601 N 3rd St, Phoenix, AZ 85004. The practice phone is (602) 265-6500.

Dr. Flitman's primary practice is 21st Century Neurology in Phoenix, Arizona. Dr. Flitman is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is 21st Century Neurology. Dmand AI also links Dr. Flitman to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Flitman practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Flitman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Flitman is board certified in neurology by the National Board of Physicians and Surgeons. Dmand AI has Dr. Flitman's licenses on file in 2 states: Arizona and Maryland.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Flitman treats.

CMS data shows 737 Medicare services from Dr. Flitman across 4 procedure codes in 2024, all of them office visits, for 347 Medicare patients. Medicare paid $69,166 for them. Every service was in an office.

CMS counts 347 Medicare patients who saw Dr. Flitman in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Flitman's median patient age at 69, with 63% women.

In 2024, Dr. Flitman wrote 4,164 Medicare Part D claims for 480 patients. 91% of them were for generic drugs. CMS names the drug for 3,790 of them, across 69 drugs with 11 or more claims each, at $765,981 in total drug cost. In 2023, CMS named 2,936 claims across 62 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Flitman for performance year 2024, reported individually.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Flitman, published from 2009 to 2010. The most frequent topics are Brain, Brain Mapping and Magnetic Resonance Imaging. Dr. Flitman has published most often in Headache. Dr. Flitman's most frequent co-author is Joshua A. Tobin, MD.

Dmand AI links Dr. Flitman to 18 clinical trials, 9 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Alzheimer Disease, Tauopathies and Parkinson Disease. Eli Lilly and Company sponsors the most, 6. Open Payments lists research payments to Dr. Flitman that name 3 trials.

CMS Open Payments shows 1,094 general payments to Dr. Flitman from 80 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. UCB, Inc. paid the most, $3,679. It also lists 16 research payments totaling $6,875 from 2016 to 2023, naming 3 clinical trials.

Dr. Flitman graduated from Albany Medical College in 1990.

Dr. Flitman is in network with 14 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.